US 7812168
Purification of montelukast
granted A61PA61P11/00A61P11/02
Quick answer
US patent 7812168 (Purification of montelukast) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P11/00, A61P11/02, A61P11/06, A61P37/08